Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies

Circulating free nucleic acids; cell free DNA and circulating micro-RNA, are found in the plasma of patients with hematologic and solid malignancies at levels higher than that of healthy individuals. In patients with hematologic malignancy cell free DNA reflects the underlying tumor mutational profi...

Full description

Bibliographic Details
Main Authors: Jay Hocking, Sridurga Mithraprabhu, Anna Kalff, Andrew Spencer
Format: Article
Language:English
Published: China Anti-Cancer Association 2016-06-01
Series:Cancer Biology & Medicine
Subjects:
DNA
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/927
id doaj-664a99a825ac4257ba1f5a16468737eb
record_format Article
spelling doaj-664a99a825ac4257ba1f5a16468737eb2020-11-25T02:03:36ZengChina Anti-Cancer AssociationCancer Biology & Medicine2095-39412095-39412016-06-0113221522510.20892/j.issn.2095-3941.2016.00252016000025Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignanciesJay Hocking0Sridurga Mithraprabhu1Anna Kalff2Andrew Spencer3Myeloma Research Group, Australian Center for Blood Diseases, Monash University, Melbourne 3004, Australia;Myeloma Research Group, Australian Center for Blood Diseases, Monash University, Melbourne 3004, Australia;Malignant Haematology & Stem Cell Transplantation Service, Alfred Hospital, Melbourne 3004, AustraliaMyeloma Research Group, Australian Center for Blood Diseases, Monash University, Melbourne 3004, Australia;Circulating free nucleic acids; cell free DNA and circulating micro-RNA, are found in the plasma of patients with hematologic and solid malignancies at levels higher than that of healthy individuals. In patients with hematologic malignancy cell free DNA reflects the underlying tumor mutational profile, whilst micro-RNAs reflect genetic interference mechanisms within a tumor and potentially the surrounding microenvironment and immune effector cells. These circulating nucleic acids offer a potentially simple, non-invasive, repeatable analysis that can aid in diagnosis, prognosis and therapeutic decisions in cancer treatment.http://www.cancerbiomed.org/index.php/cocr/article/view/927Circulating nucleic acidsDNAmiRNAhematologic malignancybiopsy
collection DOAJ
language English
format Article
sources DOAJ
author Jay Hocking
Sridurga Mithraprabhu
Anna Kalff
Andrew Spencer
spellingShingle Jay Hocking
Sridurga Mithraprabhu
Anna Kalff
Andrew Spencer
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
Cancer Biology & Medicine
Circulating nucleic acids
DNA
miRNA
hematologic malignancy
biopsy
author_facet Jay Hocking
Sridurga Mithraprabhu
Anna Kalff
Andrew Spencer
author_sort Jay Hocking
title Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
title_short Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
title_full Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
title_fullStr Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
title_full_unstemmed Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
title_sort liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
publisher China Anti-Cancer Association
series Cancer Biology & Medicine
issn 2095-3941
2095-3941
publishDate 2016-06-01
description Circulating free nucleic acids; cell free DNA and circulating micro-RNA, are found in the plasma of patients with hematologic and solid malignancies at levels higher than that of healthy individuals. In patients with hematologic malignancy cell free DNA reflects the underlying tumor mutational profile, whilst micro-RNAs reflect genetic interference mechanisms within a tumor and potentially the surrounding microenvironment and immune effector cells. These circulating nucleic acids offer a potentially simple, non-invasive, repeatable analysis that can aid in diagnosis, prognosis and therapeutic decisions in cancer treatment.
topic Circulating nucleic acids
DNA
miRNA
hematologic malignancy
biopsy
url http://www.cancerbiomed.org/index.php/cocr/article/view/927
work_keys_str_mv AT jayhocking liquidbiopsiesforliquidtumorsemergingpotentialofcirculatingfreenucleicacidevaluationforthemanagementofhematologicmalignancies
AT sridurgamithraprabhu liquidbiopsiesforliquidtumorsemergingpotentialofcirculatingfreenucleicacidevaluationforthemanagementofhematologicmalignancies
AT annakalff liquidbiopsiesforliquidtumorsemergingpotentialofcirculatingfreenucleicacidevaluationforthemanagementofhematologicmalignancies
AT andrewspencer liquidbiopsiesforliquidtumorsemergingpotentialofcirculatingfreenucleicacidevaluationforthemanagementofhematologicmalignancies
_version_ 1724947067305984000